BNGO
Bionano Genomics Inc
NASDAQ: BNGO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$1.16
-2.52% today
Updated 2026-04-29
Market cap
$13.42M
P/E ratio
—
P/S ratio
0.47x
EPS (TTM)
$-4.85
Dividend yield
—
52W range
$1 – $6
Volume
0.3M
Bionano Genomics Inc (BNGO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-125.2%
Last 4 quarters
Revenue YoY growth
-2.6%
Most recent quarter
EPS YoY growth
+99.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-11.4%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-17.8%
2026-03-24
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-24 | $-0.03 | +99.3% | $1.46 | $1.20 | -17.8% |
| 2025-11-13 | $-1.59 | -218.0% | $1.60 | $1.52 | -5.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-4.14 | $-0.03 | +99.3% | $7.95M | -2.6% |
| 2025-09-30 | $-0.50 | $-1.59 | -218.0% | $7.37M | +21.3% |
| 2025-06-30 | $-0.54 | $-1.99 | -268.5% | $6.73M | -13.4% |
| 2025-03-31 | $-3.02 | $-10.79 | -256.9% | $6.46M | -26.4% |
| 2024-12-31 | $-6.00 | $-7.73 | -28.8% | $8.16M | -23.9% |
| 2024-09-30 | $-0.21 | $-0.27 | -27.4% | $6.07M | -34.8% |
| 2024-06-30 | $-0.42 | $-0.22 | +47.6% | $7.77M | -10.3% |
| 2024-03-31 | $-0.64 | $-0.51 | +20.3% | $8.77M | +18.3% |
| 2023-12-31 | $-0.87 | $-0.96 | -10.3% | $10.72M | — |
| 2023-09-30 | $-0.97 | $-1.00 | -3.1% | $9.32M | — |
| 2023-06-30 | $-1.03 | $-1.24 | -20.4% | $8.66M | — |
| 2023-03-31 | $-0.11 | $-0.12 | -9.1% | $7.42M | — |
Frequently asked questions
Has Bionano Genomics Inc beaten earnings estimates?
Bionano Genomics Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -125.2% over the last 4 quarters.
How does BNGO stock react to earnings?
BNGO stock has moved an average of -11.4% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Bionano Genomics Inc's revenue growth rate?
Bionano Genomics Inc reported year-over-year revenue growth of -2.6% in its most recent quarter, with EPS growing +99.6% year-over-year.